GL Share Price | Globe Life, Inc. Stock Analysis & Recommendation

Q: What does Globe Life, Inc. do?

Overview: Globe Life, Inc. is an insurance holding company that provides a range of life and health insurance products and annuities, operating within the insurance industry and classified as a mid-cap company.Financial Snapshot: Net Profit: 255 Million (Quarterly Results - Mar 2025) Market Cap: USD 11,298.72 Million (Mid Cap)Key Metrics: P/E: 10.00 Dividend Yield: 0.84% Debt Equity: -999,999.00 Return on Equity: 20.53% Price to Book: 2.08Contact Details: Address: 3700 S Stonebridge Dr, MCKINNEY TX: 75070-5934 Tel: 1 972 5694000 Website: https://www.torchmarkcorp.com/

Q: Who are in the management team of Globe Life, Inc.?

As of March 2022, the management team of Globe Life, Inc. includes the following individuals:- Mr. Gary Coleman, Co-Chairman of the Board and Co-Chief Executive Officer- Mr. Larry Hutchison, Co-Chairman of the Board and Co-Chief Executive Officer- Mr. Robert Ingram, Lead Director and Independent Director- Mr. Charles Adair, Independent Director- Ms. Linda Addison, Independent Director- Ms. Marilyn Alexander, Independent Director- Ms. Cheryl Alston, Independent DirectorIn summary, the management team is led by the Co-Chairmen and Co-CEOs, Gary Coleman and Larry Hutchison, alongside several independent directors.

Q: Is Globe Life, Inc. overvalued or undervalued?

As of 23 July 2025, the valuation grade for Globe Life, Inc. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be fairly valued based on its current metrics. Key ratios include a P/E ratio of 10, a Price to Book Value of 2.12, and a PEG ratio of 0.45, which suggests that the stock may not be significantly undervalued compared to its growth prospects.In comparison to its peers, Primerica, Inc. has a P/E ratio of 12.59, while Lincoln National Corp. stands out with a very attractive P/E of 6.96. This indicates that Globe Life, Inc. is positioned in the middle of its peer group in terms of valuation. Additionally, while Globe Life has delivered a YTD return of 28.79%, outperforming the S&P 500's 12.22%, it has lagged behind the index over longer periods, particularly in the 3Y and 5Y returns. Overall, Globe Life, Inc. is fairly valued in the current market context.

Q: Is Globe Life, Inc. technically bullish or bearish?

As of 24 October 2025, the technical trend for Globe Life, Inc. has changed from bullish to mildly bullish. The weekly MACD and KST are both mildly bearish, while the monthly MACD and KST are bullish, indicating mixed signals across different time frames. The daily moving averages are mildly bullish, and the Bollinger Bands show a sideways trend on the weekly chart but mildly bullish on the monthly chart. Overall, the indicators suggest a mildly bullish stance, albeit with some caution due to the bearish signals on the weekly MACD and KST.In terms of performance, Globe Life has outperformed the S&P 500 year-to-date and over the past year, with returns of 19.82% and 22.15% respectively, compared to the S&P 500's 15.47% and 16.90%. However, over the longer-term periods of 3, 5, and 10 years, Globe Life significantly lags behind the S&P 500.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

783.78 k

Shareholding (Dec 2025)

FII

17.98%

Held by 288 FIIs

DII

36.6%

Held by 56 DIIs

Promoter

0.04%

How big is Globe Life, Inc.?

22-Jun-2025

As of Jun 18, Globe Life, Inc. has a market capitalization of $11.30 billion, with net profit of $1.07 billion and total assets of $29.08 billion.

View full answer

What does Globe Life, Inc. do?

22-Jun-2025

Globe Life, Inc. is an insurance holding company offering life and health insurance products and annuities, with a market cap of approximately $11.3 billion and a quarterly net profit of $255 million as of March 2025. Key metrics include a P/E ratio of 10.00 and a dividend yield of 0.84%.

View full answer

Who are in the management team of Globe Life, Inc.?

22-Jun-2025

As of March 2022, the management team of Globe Life, Inc. is led by Co-Chairmen and Co-CEOs Gary Coleman and Larry Hutchison, along with several independent directors, including Robert Ingram, Charles Adair, Linda Addison, Marilyn Alexander, and Cheryl Alston.

View full answer

Is Globe Life, Inc. overvalued or undervalued?

20-Sep-2025

As of July 23, 2025, Globe Life, Inc. is fairly valued with a P/E ratio of 10 and a PEG ratio of 0.45, positioned in the middle of its peers, and has delivered a YTD return of 28.79%, outperforming the S&P 500.

View full answer

Is Globe Life, Inc. technically bullish or bearish?

28-Oct-2025

As of October 24, 2025, Globe Life, Inc. shows a mildly bullish trend with mixed signals from technical indicators, having outperformed the S&P 500 year-to-date and over the past year, but lagging behind in longer-term performance.

View full answer

Compare Globe Life, Inc. with Similar Stocks

Prudential Financial, Inc.Equitable Holdings, Inc.Voya Financial, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Positive results in Jun 25

DIVIDEND PER SHARE(HY) Highest at USD 0
NET SALES(Q) Highest at USD 1,481.29 MM
RAW MATERIAL COST(Y) Fallen by 0% (YoY)

With ROE of 20.53%, it has a attractive valuation with a 2.12 Price to Book Value

Market Beating Performance

Mojo Parameters

Stock DNA

Industry

Insurance

Market cap

USD 12,684 Million (Small Cap)

P/E

11.00

Industry P/E

Dividend Yield

0.78%

Debt Equity

-999,999.00

Return on Equity

0.00%

Price to Book

0.00

Revenue and Profits:

Net Sales:

(Quarterly Results - Dec 2025)

Net Profit:

266 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-1.25%

6 Months

-4.76%

1 Year

7.74%

2 Years

17.3%

3 Years

30.22%

4 Years

39.26%

5 Years

36.75%

Globe Life, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

4.82%

EBIT Growth (5y)

-12.94%

EBIT to Interest (avg)

-0.03

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

19.33%

Dividend Payout Ratio

7.68%

Pledged Shares

Institutional Holding

97.27%

ROCE (avg)

ROE (avg)

16.46%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

EV to EBITDA

EV to Capital Employed

EV to Sales

2.12

PEG Ratio

0.94

Dividend Yield

0.78%

ROCE (Latest)

ROE (Latest)

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

Bullish

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 120 Schemes (45.36%)

Foreign Institutions

Held by 288 Foreign Institutions (17.98%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 4.27% vs -7.13% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "35.20",
          "val2": "35.70",
          "chgp": "-1.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-9.30",
          "val2": "-26.50",
          "chgp": "64.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "266.10",
          "val2": "255.20",
          "chgp": "4.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "247.20%",
          "val2": "255.50%",
          "chgp": "-0.83%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 8.44% vs 10.30% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "30.00",
          "val2": "27.00",
          "chgp": "11.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "141.20",
          "val2": "127.10",
          "chgp": "11.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-39.60",
          "val2": "-52.10",
          "chgp": "23.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,161.20",
          "val2": "1,070.80",
          "chgp": "8.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "270.10%",
          "val2": "261.10%",
          "chgp": "0.90%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY

Dec'25

Dec'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

0.00

Interest

35.20

35.70

-1.40%

Exceptional Items

-9.30

-26.50

64.91%

Consolidate Net Profit

266.10

255.20

4.27%

Operating Profit Margin (Excl OI)

247.20%

255.50%

-0.83%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is 4.27% vs -7.13% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

30.00

27.00

11.11%

Interest

141.20

127.10

11.09%

Exceptional Items

-39.60

-52.10

23.99%

Consolidate Net Profit

1,161.20

1,070.80

8.44%

Operating Profit Margin (Excl OI)

270.10%

261.10%

0.90%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 8.44% vs 10.30% in Dec 2024

All Annual Results

Company CV

About Globe Life, Inc.

Globe Life, Inc.

Insurance

Globe Life Inc., formerly Torchmark Corporation, is an insurance holding company. The Company, through its subsidiaries, provides a range of life and health insurance products and annuities to a base of customers. The Company's segments include life insurance, health insurance, annuities and investment. The life insurance segment includes traditional and interest-sensitive whole life insurance as well as term life insurance. The Health insurance products are guaranteed-renewable and include Medicare Supplement, critical illness, accident and limited-benefit supplemental hospital and surgical coverage's. Annuities include fixed-benefit contracts. The Company markets its insurance products through various distribution channels, each of which sells the products of its insurance segments. Its subsidiaries include American Income Life Insurance Company (American Income) and Liberty National Life Insurance Company (Liberty National).

Company Coordinates

Company Details

3700 S Stonebridge Dr , MCKINNEY TX : 75070-5934

Tel: 1 972 5694000

https://www.torchmarkcorp.com/

Registrar Details